News &
Media
Latest News
AFGN-Funding Opportunity Round 2: FxGx platforms to assess multiple VUS in priority genes
New funding opportunity for functional genomics platforms to resolve multiple VUS in priority genes for Australian diagnostic laboratories and clinicians. Projects will be eligible for catalyst
Phenomics Australia Survey 2024
Welcome to Phenomics Australia Survey 2024 This survey is being undertaken by Phenomics Australia and should take 5-10 minutes to complete. Whether you’re a repeat user
Researchers identify therapies to limit COVID-19 risk in people with Down syndrome
Australian Institute for Bioengineering and Nanotechnology (AIBN) Senior Research Fellow Dr Mohammed Shaker and Phenomics Australia Scientific Director Professor Ernst Wolvetang, head of the In vitro Genome Engineering and
Integrating Advanced Data Solutions for Melanoma Prevention and Detection
Phenomics Australia Board member Prof. Graham Mann and Deputy CEO A/Prof. Jim Hennessy were pleased to join fellow NCRIS members, including Population Health Research Network, Therapeutic
Improving laboratory animal genetic reporting:LAG-R guidelines
The LAG-R framework (Laboratory Animal Genetic Reporting) has just been published in Nature Communications. The LAG-R framework is a set of guidelines to support more complete
A collaboration of scientists from 16 institutes worldwide discovers a gene linked to the severity of respiratory viral infections
Led by the Peter Doherty Institute for Infection and Immunity, and supported by services from Phenomics Australia, researchers revealed the critical role of a gene called
Non-executive Director – Board member Phenomics Australia
Closing date: 5:00pm AEST, 30 September 2024. We are seeking a non-executive director to join the Phenomics Australia Board. Please share with your networks. Non-executive Director
Recap of the High-Content Analysis Workshop in Melbourne: Exploring Cutting-Edge Techniques and Applications
In May, the Phenomics Australia Victorian Centre for Functional Genomics (VCFG) node in collaboration with Thermo Fisher, hosted a dynamic two-day workshop in Melbourne, focused on
Voucher scheme to support translational research is now open for applications
Pipeline Accelerator 2024-25 Round 1 To encourage access to research infrastructure, Therapeutic Innovation Australia (TIA) developed the Pipeline Accelerator, a voucher-style scheme that subsidises the cost of access
Contribute to our news
Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.